Validation of a rapid method to quantify apoptosis in superficial bladder cancer

British Journal of Urology

Volumn 80, Issue 6, 1997, Pages 927-932

  Kelly, J D ^a   Hamilton, P W ^a   Williamson, K E ^a   Weir, H P ^a   Mcmanus, D T ^a   Keane, P F ^a   Johnston, S R ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Bladder cancer; Chemotherapy; Quantification

Indexed keywords

MITOMYCIN;

APOPTOSIS; ARTICLE; BLADDER CANCER; CELL COUNT; CHEMOSENSITIVITY; CLINICAL ARTICLE; HUMAN; HUMAN CELL; MICROSCOPY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; STATISTICS; SUPERFICIAL CANCER; TRANSITIONAL CELL CARCINOMA;

EID: 0031400659     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1997.00485.x     Document Type: Article

References (20)

1. Kerr JFR, Harmon BV. Definition and incidence of apoptosis: an historical perspective. In Tomei LD, Cope FO eds. Apoptosis: The Molecular Basis of Cell Death, Vol 1. Cold Spring Harbour Laboratory Press, 1991: 5-21
2. Wyllie AH. Apoptosis (The 1992 Frank Rose Memorial Lecture). Br J Cancer 1993; 67: 205-8
3. Barry MA, Behnke CA, Eastman A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 1990; 40: 2352-62
4. Carson DA, Ribeiro JM. Apoptosis and disease. Lancet 1993 341: 1251-4
5. Lipponen PK, Aaltoma S. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis. J Pathol 1994; 173: 333-9
6. Goodlad RA, Levi S, Lee CY, Mandir N, Hodgson H, Wright NA. Morphometry and cell proliferation in endoscopic biopsies: evaluation of a technique. Gastroenterology 1991; 101: 1235-41
7. Haapasalo H, Collan Y, Pesonen E. Volume corrected mitotic index (M/V index): the standard of mitotic activity in neoplasms. Pathol Res Pract 1989; 185: 551-4
8. Hilsenbeck SG, Allred DC. Improved methods of estimating mitotic activity in solid tumours. Hum Pathol 1992; 23: 601-2
9. Lipponen P, Aaltoma S, Kosma VM, Syrjanen K. Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer 1994; 30A: 2068-73
10. Simpson JF, Dutt PL, Page MD. Expression of mitosis per thousand cells and cell density in breast carcinomas: a proposal. Hum Pathol 1992; 23: 608-11
11. Elston C, Ellis I. Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer. Histopath 1991; 19: 403-10
12. Walker NI, Harmon BV, Gobe GC, Kerr JFR. Patterns of cell death. Med Arch Exp Pathol 1988; 13: 18-54
13. Hamilton PW, Allen DC Mitotic Counts. In Hamilton PW, Allen DC, eds, Quantitative Clinical Pathology. 1st edn. Oxford: Blackwell Science, 1995: 23-7
14. Bland J, Altman D. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-10
15. van de Schepop HAM, de Jong JS, van Diest PJ, Baak JPA. Counting of apoptotic cells: a methodological study in invasive breast disease. J Clin Pathol Mol Pathol 1996; 49: 214-7
16. Potten C. What is an apoptotic index measuring? Commentary. Br J Cancer 1996; 74: 1743-8
17. Harrison D. Counting apoptosis - why and how? J Clin Pathol Mol Pathol 1996; 49: M245-M246
18. Ansari B, Coates PJ, Greenstein BD, Hall PA. In situ end labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 1993; 170: 1-8
19. Wijsman JH, Jonker RR, Keijzer REA. A new method to detect apoptosis in paraffin sections: in situ end-labelling of fragmented DNA. J Histochem Cytochem 1993; 41: 7-12
20. van Diest PJ, Baak JPA, Matze-Cok P et al. Reproducibility of mitosis counting in 2469 breast cancer specimens: results from the multicentre morphometric mammary carcinoma project. Hum Pathol 1992; 23: 603-7